Lombard Odier Asset Management (USA)’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
2016
Q3
$768K Sell
2016
Q2
$436K Buy
2016
Q1
$449K Sell
2015
Q4
$1.18M Buy
2015
Q3
$1.69M Buy
2015
Q2
$1.98M Buy